首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A surrogate analyte-based LC-MS/MS method for the determination of 7-hydroxybutyrate (GHB) in human urine and variation of endogenous urinary concentrations of GHB
【24h】

A surrogate analyte-based LC-MS/MS method for the determination of 7-hydroxybutyrate (GHB) in human urine and variation of endogenous urinary concentrations of GHB

机译:基于替代分析物的LC-MS / MS方法测定人尿液中7-羟基丁酸酯(GHB)和内源性尿GHB浓度的变化

获取原文
获取原文并翻译 | 示例
           

摘要

gamma-Hydroxybutyrate (GHB) is a drug of abuse with a strong anesthetic effect; however, proving its ingestion through the quantification of GHB in biological specimens is not straightforward due to the endogenous presence of GHB in human blood, urine, saliva, etc. In the present study, a surrogate ana-lyte approach was applied to accurate quantitative determination of GHB in human urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in order to overcome this issue. For this, ~2H_6-GHB and ~(13)C_2-DL-3-hydroxybutyrate were used as a surrogate standard and as an internal standard, respectively, and parallelism between the surrogate anaiyte approach and standard addition was investigated at the initial step. The validation results proved the method to be selective, accurate, and precise, with acceptable linearity within calibration ranges (0.1-1 mug/ml). The limit of detection and the limit of quantification of ~2H_6-GHB were 0.05 and 0.1 fxg/ml, respectively. No significant variations were observed among urine matrices from different sources. The stability of ~2H_6-GHB was satisfactory under sample storage and in-process conditions. However, in vitro production of endogenous GHB was observed when the urine sample was kept under the in-process condition for 4h and under the storage conditions of 4 and -20degC. In order to facilitate the practical interpretation of urinary GHB, endogenous GHB was accurately measured in urine samples from 79 healthy volunteers using the surrogate analyte-based LC-MS/MS method developed in the present study. The unadjusted and creatinine-adjusted GHB concentrations in 74 urine samples with quantitative results ranged from 0.09 to 1.8 fig/ml and from 4.5 to 530 mug/mmol creatinine, respectively. No significant correlation was observed between the unadjusted and creatinine-adjusted GHB concentrations. The urinary endogenous GHB concentrations were affected by gender and age while they were not significantly influenced by habitual smoking, alcohol drinking, or caffeine-containing beverage drinking.
机译:γ-羟基丁酸酯(GHB)是一种滥用药物,具有很强的麻醉作用;然而,由于人体血液,尿液,唾液等中存在内源性GHB,因此无法通过生物样本中的GHB定量来证明其摄入是直接的。在本研究中,采用替代分析物方法进行准确的定量测定液相色谱-串联质谱法(LC-MS / MS)测定人尿中GHB的含量,以解决此问题。为此,分别将〜2H_6-GHB和〜(13)C_2-DL-3-羟基丁酸酯用作替代标准品和作为内部标准品,并在初始步骤研究替代替代品方法与标准品添加之间的平行性。验证结果证明该方法是选择性,准确和精确的,并且在校准范围内(0.1-1杯/毫升)具有可接受的线性。 〜2H_6-GHB的检出限和定量限分别为0.05和0.1 fxg / ml。在不同来源的尿液基质之间未观察到显着差异。 〜2H_6-GHB在样品存储和加工条件下的稳定性令人满意。然而,当尿液样品在过程中条件下保持4h并在4和-20℃的存储条件下观察到内源性GHB的体外产生。为了促进尿GHB的实际解释,使用本研究开发的基于替代分析物的LC-MS / MS方法,从79位健康志愿者的尿液样本中准确测量了内源性GHB。 74个尿液样本中未经调整和经肌酐调整的GHB浓度,定量结果分别为0.09至1.8 fig / ml和4.5至530杯/毫摩尔肌酐。在未调节和肌酐调节的GHB浓度之间未观察到显着相关性。尿中内源性GHB的浓度受性别和年龄的影响,而习惯性吸烟,饮酒或含咖啡因的饮料的饮用对尿中内源性GHB的浓度没有明显影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号